Physician profile
Ralph W Raper
NPI 1306817523
$3,442.49
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,829 · 2020: $335 · 2021: $764 · 2022: $515.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $571.97 | 2019-2022 | |
| Pfizer INC. | $325.61 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $312.04 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $292.82 | 2019-2022 | |
| Astellas Pharma US INC | $284.34 | 2019-2022 | |
| Amgen INC. | $224.08 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $205.56 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $194.06 | 2019-2021 | |
| Allergan, INC. | $182.01 | 2019 | |
| Sanofi-Aventis U.S. LLC | $140.09 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.83 | 2019 | |
| Lilly USA, LLC | $125.48 | 2019-2022 | |
| Novo Nordisk INC | $73.27 | 2019-2021 | |
| Horizon Therapeutics Plc | $54.91 | 2021-2022 | |
| Glaxosmithkline, LLC. | $53.39 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $38.83 | 2021 | |
| Eisai INC. | $38.48 | 2019 | |
| Urovant Sciences INC | $34.27 | 2022 | |
| Biogen, INC. | $32.80 | 2021 | |
| Acadia Pharmaceuticals INC | $19.22 | 2021 | |
| Amarin Pharma, INC. | $17.33 | 2022 | |
| Sanofi Pasteur INC. | $12.50 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $11.27 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Raper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.